Viatris Stock

Viatris PEG

PEG Ratio (Price/Earnings-to-Growth) of Viatris (VTRS) as of Aug 20, 2026.

PEG

0.00

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Viatris is 2026 0.00 . PEG Ratio (Price/Earnings-to-Growth) of Viatris was 2025 0.00 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Viatris Stock analysis

What does Viatris do? Viatris Inc. is a global pharmaceutical company that was formed in 2020 through the merger of Mylan and Upjohn. Headquartered in Pennsylvania, USA, the company operates in over 165 countries. Viatris is one of the largest generic and biosimilar manufacturers worldwide. Viatris is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Viatris stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Viatris since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Viatris with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Viatris

All Key Metrics — Viatris